Jan 30 (Reuters) - Cigna Group CI.N:
PUBLIC SCRUTINY FOLLOWING UNITEDHEALTH SHOOTING CHALLENGED CIGNA TO INCREASE TRANSPARENCY, EXEC SAYS
CIGNA EXEC SAYS WILL FOCUS ON MAKING PRIOR AUTHORIZATIONS FASTER - CONF. CALL
CIGNA EXEC SAYS SAW AN INCREASE IN HIGH COST CLAIMS DUE TO PRESCRIPTION AND USE OF SPECIALITY DRUGS
CIGNA EXEC SAYS WILL CONTINUE TO EVALUATE BOLT ON ACQUISITIONS
Further company coverage: CI.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.